Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 18 tags : Fda save search
Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, Cellulite Reduction and Muscle Conditioning
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
VERO | $0.787 -6.79% -7.28% 19K
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
fda clearance cel
Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
RVNC | $3.665 0.69% 0.68% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
fda xin injection submission resubmission
Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery
Published: 2022-01-18 (Crawled : 16:00) - biospace.com/
SRGA | $0.1829 -50.36% 8.7M
|
Health Technology
|
| O: 20.57%
H: 5.88%
C: -21.35%
fda clearance system fda clearance spine
Dyne Therapeutics Announces FDA Clinical Hold on IND Application for DYNE-251 in Duchenne Muscular Dystrophy
Published: 2022-01-18 (Crawled : 15:30) - biospace.com/
DYN | $25.44 2.29% 2.24% 810K
|
Health Technology
|
| O: -15.82%
H: 6.78%
C: 3.84%
dyne-251 clinical hold fda muscular dystrophy application therapeutics duchenne
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Chronic Chemotherapy Induced Peripheral Neuropathy (CIPN) with its Wearable Neurostimulation Technology
Published: 2022-01-18 (Crawled : 15:30) - biospace.com/
NURO A | $4.44 -2.85% -2.93% 28K
|
Health Technology
|
| O: 23.17%
H: 22.28%
C: 5.12%
treatment fda device technology therapy designation
Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore™ for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
ADTX | $2.285 2.93% 2.84% 26K
|
Health Technology
|
| O: 2.73%
H: 1.66%
C: -6.11%
covid-19 fda covid authorization test merge antibody emergency use authorization
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
CELU | News F | $3.3 7.84% 7.27% 20K
|
|
| O: 4.83%
H: 0.0%
C: -12.21%
cynk-101 fast track designation treatment fda fast track cel positive therapy cancer her2- her2
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.81%
H: 11.07%
C: -3.92%
skinte fda fda approval skin approval phase 3
HOOKIPA Announces First Patient Enrolled in Phase 2 Trial Evaluating HB-200 and Pembrolizumab for Treatment of Head and Neck Cancer and Reports FDA’s Fast Track Designation
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
HOOK | $0.7801 10.34% 9.37% 790K
|
Health Technology
|
| O: 0.0%
H: 2.44%
C: -1.46%
hb-200 fast track designation treatment fda phase 2 fast track trial report cancer enroll designation
BioLineRx Announces Successful Completion of Pre-NDA Meeting with FDA for Motixafortide for Stem Cell Mobilization in Multiple Myeloma Patients
Published: 2022-01-18 (Crawled : 14:00) - biospace.com/
BLRX | $0.6368 -5.95% -6.33% 420K
|
Health Technology
|
| O: 7.61%
H: 3.3%
C: 2.83%
fda cel stem cell
Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis- Positive feedback from FDA to initiate Phase 3 trial of atacicept in patients with LN -
Published: 2022-01-18 (Crawled : 13:30) - biospace.com/
VERA | $39.46 0.84% 0.84% 1.2M
|
Professional, Scientific, and T...
|
| O: -8.03%
H: 8.58%
C: 2.84%
fda trial therapeutics positive phase 3 lupus
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: -4.24%
atrs-1902 fast track designation fda fast track renal fda fast track designation pharma
CASI PHARMACEUTICALS ANNOUNCES CNCT19 (CD19 CAR-T) GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
CASI | $2.42 -0.41% -0.41% 12K
|
Health Technology
|
| O: -5.62%
H: 3.48%
C: -6.69%
cnct19 fda als car-t drug granted orphan drug grant designation
Celcuity Receives FDA Fast Track Designation for Gedatolisib in HR+ / HER2- Metastatic Breast Cancer and Provides Corporate Update
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
CELC | $17.29 -1.43% -1.45% 91K
|
Commercial Services
|
| O: -2.16%
H: 7.88%
C: 2.12%
fast track designation fda fast track cel fda fast track cancer breast cancer designation her2- her2 metastatic breast cancer
bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD)
Published: 2022-01-18 (Crawled : 12:30) - biospace.com/
BLUE | $0.9739 2.13% 2.08% 4.8M
|
Health Technology
|
| O: -3.19%
H: 1.0%
C: -6.94%
fda cel
ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC
Published: 2022-01-18 (Crawled : 12:00) - admabiologics.com
ADMA 4 | $6.535 5.4% 5.13% 2.7M
|
Health Technology
|
| O: 7.34%
H: 0.0%
C: 0.0%
fda fda approval approval
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.